Rezk Francis, Åstrand Håkan, Acosta Stefan
1 Lund University, Lund, Sweden.
2 Jönköping Hospital, Jönköping, Sweden.
Int J Low Extrem Wounds. 2019 Jun;18(2):135-142. doi: 10.1177/1534734619838749. Epub 2019 Apr 23.
Due to the consistently high proportion of surgical site infections (SSI) after vascular surgery, a change of prophylactic antibiotic therapy from to was conducted in 2016. The study included consecutive patients undergoing lower extremity revascularization due to acute or chronic lower extremity arterial disease. The antibiotic regime was changed in between the two sampling periods (2014 -2016 versus 2016 -2017). The diagnosis of SSI was based on clinical examination and microbiological results, and severity was classified according to the Szilagyi classification. One hundred and twenty-two patients in the and 67 patients in the group were included. The SSI rates were 32.0% and 40.3%, respectively (p=0.25). The proportion of women were higher in the group (32.8% versus 47.8%, respectively, p=0.043). No other differences between the two groups were found regarding patient, vascular surgery procedure characteristics or severity of SSI. Groin infection rate was higher in the group (15.4% versus 30.5%, respectively, p=0.022). When adjusting for gender, groin infection was more common in the group (Odds Ratio 2.5, 95% CI 1.1 -5.4). The groin SSI rate was higher after elective surgery in the group (13.0% versus 27.8%, respectively, p=0.027), and also after adjusting for gender (Odds Ratio 2.6, 95% CI 1.1 -6.2). The change in antibiotic prophylaxis from to was associated with an increased rate of inguinal SSI in patients undergoing lower extremity revascularization, despite a possible Hawthorne effect.
由于血管手术后手术部位感染(SSI)的比例一直居高不下,2016年进行了预防性抗生素治疗的变更,从[具体药物1]改为[具体药物2]。该研究纳入了因急性或慢性下肢动脉疾病接受下肢血管重建术的连续患者。在两个采样期之间(2014 - 2016年与2016 - 2017年)改变了抗生素治疗方案。SSI的诊断基于临床检查和微生物学结果,严重程度根据西拉吉分类法进行分类。[具体药物1]组纳入了122例患者,[具体药物2]组纳入了67例患者。SSI发生率分别为32.0%和40.3%(p = 0.25)。[具体药物2]组女性比例更高(分别为32.8%和47.8%,p = 0.043)。在患者、血管外科手术程序特征或SSI严重程度方面,两组之间未发现其他差异。[具体药物2]组腹股沟感染率更高(分别为15.4%和30.5%,p = 0.022)。在对性别进行调整后,[具体药物2]组腹股沟感染更为常见(优势比2.5,95%可信区间1.1 - 5.4)。在[具体药物2]组中,择期手术后腹股沟SSI发生率更高(分别为13.0%和27.8%,p = 0.027),在对性别进行调整后也是如此(优势比2.6,95%可信区间1.1 - 6.2)。尽管可能存在霍桑效应,但从[具体药物1]到[具体药物2]的抗生素预防措施变更与接受下肢血管重建术患者的腹股沟SSI发生率增加有关。